1 Product identity
Ingredient risk
Contains restricted ingredients

St. John's Wort 300 mg

BrandRadiance→Botanical Capsule 5 ingredients 1 banned 1 caution DSLD #45930
Net contents: 100 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2015-05-22
2 Ingredients (5)
IngredientGroupSafety
St. John's Wort extractSt. John's WortBanned in ≥1 country
GelatinGelatin—
Dicalcium PhosphateCalciumConditionally Safe
SilicaSiliconGenerally Safe
Vegetable Magnesium StearateMagnesium stearateUse with Caution
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
St. John's Wort  🇫🇷 🇯🇵 🇰🇷 — dards. Drug interaction warnings required [2]. || France :: Banned from sale as a supplement (2000) due to drug interaction concerns [3]. ||
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
St. John's Wort — Banned in ≥1 country
⚠ MAJOR CYP3A4 INDUCER — interacts with >50% of drugs
⚠ Serotonin syndrome with SSRIs
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Silicon — Generally Safe
⚠ Very low toxicity
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID45930
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2015-05-22
6 More from Radiance
View Radiance Safety Scorecard → 7 products
Bee Pollen Complex 1000 PlusEvening Primrose Oil 1000 mgFlaxseed Oil 1200 mgLycopene 10 mgOriginal Papaya EnzymeSilymarin Milk Thistle 175 mg
7 Cite this page
Vancouver
Pkhakadze G. St. John's Wort 300 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 20]. Available from: https://supplement.ge/products/st-johns-wort-300-mg-45930/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
© 2026 supplement.ge · PHIG · Sheni Network
Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network